Dental care linked to risk of respiratory infections in ICU patients

Article

The study was published in Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA).

New research shows vulnerable patients in the Intensive Care Unit (ICU) who received enhanced oral care from a dentist were at significantly less risk for developing a lower respiratory tract infection (LRTI), like ventilator-associated pneumonia, during their stay in the hospital.

The study was published in Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA).

"Bacteria causing healthcare-associated infections often start in the oral cavity," said Fernando Bellissimo-Rodrigues, MD, lead author of the study. "This study suggests that having a dentist provide weekly care as part the ICU team may improve outcomes for vulnerable patients in this setting."

Related reading: New discovery could increase protection against dental infection

Brazilian researchers utilized an observer-blind randomized clinical trial design to analyze data from 254 adult patients who stayed in a general ICU for at least 48 hours. Patients were randomized to receive enhanced dental care provided by a dentist, or to receive routine oral hygiene performed by the ICU nurse staff.

Enhanced dental care included teeth brushing, tongue scraping, removal of calculus, atraumatic restorative treatment of caries, tooth extraction and topical application of chlorhexidine corresponding to each patients' needs four to five times a week. Comparatively, regular treatment consisted of mechanical cleansing using gauze followed by topical application of chlorhexidine three times a day.  

Patients provided enhanced dental care were 56 percent less likely to develop a respiratory tract infection during their ICU stay compared to the control patient group. Researchers note that enhanced dental treatment, including oral antisepsis routinely performed in ICUs could be more effective in reducing the oral bacteria and help prevent migration of these bacteria into the lungs.

This post is reprinted from materials provided by Society for Healthcare Epidemiology of America. Materials may be edited for length and content.

 

Recent Videos
Karen Gregory talks about instrument processin and the Lexa sterilizers by W&H at the DPR booth at GNYDM24.
DS World 2024 Interview with Katrina Sanders, RDH
2024 Dental Products Report Spring Selection Bracket Reveal Video
CDS 2024 Midwinter Meeting – Interview with Debbie Zafiropoulos, who discusses a trio of new infection control products from Armis Biopharma.
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
CDS 2024: Breaking Down Barriers to Care with Eric Kukucka, DD
GNYDM23 Product Focus: Henry Schein Maxima Turbo Class B Sterilizer with Dyan Jayjack
GNYDM23 Product Focus: Henry Schein Maxima PowerClean 210 with Dyan Jayjack
GNYDM23 Product Focus: CandidPro with Kristin Lange, VP of Sales at Candid
Related Content
© 2024 MJH Life Sciences

All rights reserved.